Search

everythinglearnresearchcommunity

for

Search:↓

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

Iron deficiency worsens inflammatory skin diseases by disrupting iron balance and increasing inflammation.

Changes in skin microbes play a role in some skin diseases and could lead to new treatments.

BMD-1141 effectively regrows hair in alopecia areata with less frequent dosing than current treatments.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

Balancing skin microbiota is crucial for healthy skin and treating skin diseases.

MicroRNAs may help diagnose and treat hair loss disorders.

Alopecia areata may be linked to scalp microbiome differences, suggesting potential treatments with prebiotics, probiotics, and postbiotics.

A patient developed a severe skin reaction and died after taking hydroxychloroquine for COVID-19.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

WNT10A mutations cause varied symptoms in patients with odonto-onycho-dermal dysplasia.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Higher IL-17A levels indicate more severe alopecia areata.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

Chemical exposure may contribute to the rise in atopic diseases and needs more research.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Topical treatments led to hair regrowth in a man with linear morphea.

Pumpkin seeds may help expel parasites, but findings are retracted.

Apremilast did not work for treating severe alopecia areata.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.

Air pollution worsens skin diseases and aging by causing inflammation and oxidative stress.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

A medication may help with hair growth in psoriasis, and a skin condition might be linked to a specific bacteria.

Ustekinumab might work for severe psoriasis, but more research is needed to be sure.

Oxidative stress may contribute to hair loss in alopecia areata and antioxidants could potentially help as a treatment.

Glycemic control medications for Type 2 diabetes can affect skin conditions like psoriasis.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.